WhiteOak Capital Pharma and Healthcare Fund Regular-Growth
Equity
Sectoral-Pharma
₹-0.65% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
- Rating
Not Rated - Minimum Investment₹500
- NAV (Net Asset Value)₹N/A
- AUM (Fund size)₹825 Cr
- Created on2 Feb 2024
Fund Ranking
#
/ 16 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
- 6 Month22.9%
- 1 Year20.0%
- 3 Year (CAGR)-
- All Time (CAGR)22.2%
Category Return
- 6 Month17.3%
- 1 Year16.6%
- 3 Year (CAGR)20.9%
- All Time (CAGR)17.1%
Asset Allocation
- Equity99.2%
- Debt5.9%
- Other-5.1%
Top 5 Holdings
Top 5 Sectors
- Apollo Hospitals Enterprise4.30%
- Apollo Hospitals Enterprise0.26%
- Aurobindo Pharma2.52%
- Aurobindo Pharma1.73%
- Cipla3.04%
Fund Information
- Expense Ratio2.77%
- Exit LoadNo Exit Load
- Lock-In PeriodNo Lock-In
Risk & Return Ratio
- Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance. 0.00 - Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment. 0.00 - Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance. 0.00 - Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility. 0.00